Emulate
Latest round
- —
Last raised
- Sep 2026
Total raised
- $833M
Investors
- 10
About Emulate
Emulate, Inc.Founded in 2014 and headquartered in Boston, US, Emulate, Inc. develops organ-on-a-chip solutions to advance drug research.Emulate's flagship product, the AVA™ Emulation System, enables high-throughput testing with up to 96 Organ-Chip samples, streamlining the evaluation of drug candidates. The Zoë-CM2® Culture Module facilitates the creation of functional human biological models, aiding in drug target identification and validation.Emulate generates revenue through direct sales of its organ-on-a-chip systems, consumables, and ongoing support services. plans to scale up its research and development to introduce new organ-on-a-chip models focused on immunology, neuroinflammation, and tumor modeling.49 mn to enhance its development capabilities.
Who invested in Emulate
10 investors across 5 rounds
See all investors in Emulate
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Emulate
Who invested in Emulate?
Emulate has 10 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Emulate raised?
Emulate has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
What does Emulate do?
Emulate is a biotechnology company.
Where is Emulate headquartered?
Emulate is headquartered in Boston, US.
Which VCs invest in companies like Emulate?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Emulate's stage. Their profiles are linked below.
VCs backing biotechnology startups
Raising like Emulate? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.